Trilexium - CAS 1983180-82-0

Trilexium (TRX-E-009-1), a third-generation benzopyran structurally related to TRX-E-002-1, increases p21 protein expression, induces apoptosis, depolymerizes microtubules, and demonstrates broad anti-cancer activity [1] [2].

Microtubule Associated, Caspase, PARP, Apoptosis

Proteases/Proteasome, Chromatin/Epigenetic, Apoptosis, DNA Damage/DNA Repair, Cytoskeletal Signaling

1983180-82-0

C24H23FO6

426.43

-20°C

Ice Packs

Small Compound